SHAREHOLDER ALERT: Weiss Law Reminds SHBI, BNFT, IMRA, and APEN Shareholders About Its Ongoing Investigations

Mann mit Wirtschaftszeitung (Symbolbild). pixabay.com

PR Newswire

NEW YORK, Jan. 11, 2023

NEW YORK, Jan. 11, 2023 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Shore Bancshares, Inc. (NASDAQ: SHBI)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Shore Bancshares, Inc. (NASDAQ: SHBI), in connection with the proposed merger of SHBI with The Community Financial Corporation. If you own SHBI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/shbi

Benefitfocus, Inc. (NASDAQ: BNFT)

ARIVA.DE Börsen-Geflüster

Kurse

0,00%

0,00%

0,00%

9,50 €

0,00%

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Benefitfocus, Inc. (NASDAQ: BNFT), in connection with the proposed acquisition of BNFT by Voya Financial, Inc. Under the terms of the merger agreement, BNFT shareholders will receive $10.50 in cash for each share of BNFT common stock owned. If you own BNFT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/bnft

IMARA Inc. (NASDAQ: IMRA)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IMARA Inc. (NASDAQ: IMRA) in connection with the proposed merger of IMRA with Enliven Therapeutics, Inc. ("Enliven"). Under the terms of the merger agreement, IMRA will issue IMRA common stock as merger consideration in exchange for the cancellation of shares of capital stock of Enliven and Enliven will become a wholly owned subsidiary of IMRA. If you own IMRA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/imra

Apollo Endosurgery, Inc. (NASDAQ: APEN)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apollo Endosurgery, Inc. (NASDAQ: APEN), in connection with the proposed acquisition of APEN by Boston Scientific Corporation. Under the terms of the merger agreement, APEN shareholders will receive $10.00 in cash for each share of APEN common stock owned. If you own APEN shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/apen

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-shbi-bnft-imra-and-apen-shareholders-about-its-ongoing-investigations-301718568.html

SOURCE Weiss Law

Mehr Nachrichten zur Shore Bancshares Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.